The FDA says the OTC remedy maker's online behavior—including Liking customer Facebook posts—has put the company's drugs in unapproved drug territory.
The $14.2-billion deal is expected to close in the second half of this year.
The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.
Pfizer's consumer website for Advil in South Korea offers a strange appeal to women who experience menstrual pain.
Mintel finds consumers are wary about how OTC stomach medicines, like Rolaids, may affect their health.
J&J's campaign picks up where the FDA left off when it alerted physicians to concerns about prescribing acetaminophen-containing drugs but deferred action relative to OTC products.
*Group discounts available on request
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.